Acadia Healthcare Company, Inc. current report, 06 January 2016

Acadia Healthcare Company, Inc. - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K covers events occurring on January 6, 2016, with the report filed on January 8, 2016. The filing details a material definitive agreement regarding a public equity offering and an amendment to a pending acquisition agreement for the Priory Group, a UK-based behavioral healthcare provider.

Key Financial Metrics and Transaction Details

  • Offering Size: 10,000,000 shares of Common Stock (Firm Shares).
  • Offering Price: $61.00 per share.
  • Underwriters' Option: 30-day option to purchase up to 1,500,000 additional shares.
  • Net Proceeds: Approximately $594.8 million (excluding the Underwriters' Option).
  • Acquisition Consideration: The amendment adjusts the consideration for the Priory Group acquisition to approximately $337.5 million (approx. £225 million), valued at the public offering price.

Note: This filing does not provide standard operating financial metrics such as revenue, profit, cash flow, margins, or debt levels for a specific reporting period.

Material Changes and Agreements

Acadia entered into an Underwriting Agreement with Merrill Lynch, Pierce, Fenner & Smith Incorporated and Jefferies LLC. Concurrently, the company amended its Sale and Purchase Deed for the Priory Group acquisition. The amendment allows Institutional Sellers to receive cash proceeds from the sale of up to 1.5 million shares (if the underwriters' option is exercised) in lieu of stock, while Acadia agreed to issue additional shares to ensure the total consideration remains approximately $337.5 million.

Use of Proceeds, Outlook, and Risks

Acadia intends to use the net proceeds principally to fund its acquisition strategy, specifically to fund a portion of the purchase price for the Priory Group and related transaction fees and expenses. The closing of the Firm Shares sale is scheduled for or about January 12, 2016.

Key contingencies and risks include:

  • Completion of the offering and the Priory Group acquisition.
  • Exercise of the Underwriters' Option, which affects the share count issued to Institutional Sellers.
  • 60-day "lock-up" agreements entered into by major investors (Waud Capital Partners, Bain Capital, Advent International) and company directors/officers.

Investor Verification Checklist

  • Verify the final closing date of the offering (scheduled for approx. January 12, 2016).
  • Confirm whether the Underwriters exercise the option to purchase the additional 1,500,000 shares.
  • Review the full text of the Underwriting Agreement (Exhibit 1) and the Amendment to the Sale and Purchase Deed (Exhibit 2) for specific covenants and conditions.
  • Monitor the status of the Priory Group acquisition closing and regulatory approvals.